"Oropharyngeal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the OROPHARYNX.
| Descriptor ID |
D009959
|
| MeSH Number(s) |
C04.588.443.665.710.684 C07.550.745.671 C09.647.710.685 C09.775.549.685
|
| Concept/Terms |
Oropharyngeal Neoplasms- Oropharyngeal Neoplasms
- Neoplasm, Oropharyngeal
- Oropharyngeal Neoplasm
- Oropharynx Neoplasms
- Neoplasm, Oropharynx
- Neoplasms, Oropharynx
- Oropharynx Neoplasm
- Neoplasms, Oropharyngeal
Cancer of Oropharnyx- Cancer of Oropharnyx
- Oropharnyx Cancer
- Oropharnyx Cancers
- Oropharyngeal Cancer
- Cancer, Oropharyngeal
- Cancers, Oropharyngeal
- Oropharyngeal Cancers
- Oropharynx Cancer
- Cancer, Oropharynx
- Cancers, Oropharynx
- Oropharynx Cancers
- Cancer of the Oropharynx
|
Below are MeSH descriptors whose meaning is more general than "Oropharyngeal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Oropharyngeal Neoplasms".
This graph shows the total number of publications written about "Oropharyngeal Neoplasms" by people in this website by year, and whether "Oropharyngeal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 0 | 1 |
| 2000 | 1 | 1 | 2 |
| 2001 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 3 | 0 | 3 |
| 2013 | 3 | 0 | 3 |
| 2014 | 2 | 0 | 2 |
| 2015 | 7 | 0 | 7 |
| 2016 | 6 | 0 | 6 |
| 2017 | 5 | 0 | 5 |
| 2018 | 5 | 0 | 5 |
| 2019 | 4 | 0 | 4 |
| 2020 | 7 | 1 | 8 |
| 2021 | 2 | 0 | 2 |
| 2022 | 4 | 0 | 4 |
| 2023 | 2 | 0 | 2 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Oropharyngeal Neoplasms" by people in Profiles.
-
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled Trial. JAMA Oncol. 2024 Jul 01; 10(7):923-931.
-
Stepped Behavioral and Biological Screening for Oral Oncogenic HPV DNA in Middle-aged and Elderly Adults: A Feasibility Study. Cancer Prev Res (Phila). 2023 03 01; 16(3):127-132.
-
Personalizing Surveillance in Head and Neck Cancer. Am Soc Clin Oncol Educ Book. 2023 01; 43:e389718.
-
Feasibility of clinical evaluation of individuals with increased risk for HPV-associated oropharynx cancer. Head Neck. 2023 Jan; 45(1):95-102.
-
Association of HPV status with survival after surgical salvage of oropharyngeal cancers. Am J Otolaryngol. 2022 Jul-Aug; 43(4):103491.
-
Development and Validation of a Decision Analytical Model for Posttreatment Surveillance for Patients With Oropharyngeal Carcinoma. JAMA Netw Open. 2022 04 01; 5(4):e227240.
-
Induction Chemotherapy in Low-Risk HPV+ Oropharyngeal Cancer. Curr Treat Options Oncol. 2022 01; 23(1):54-67.
-
Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment. BMC Cancer. 2022 Jan 03; 22(1):17.
-
Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience. Oral Oncol. 2021 11; 122:105566.
-
Chemoradiation for Anal Cancer: Clinical Outcomes and Strategies to Optimize the Therapeutic Ratio According to HPV Status. Semin Radiat Oncol. 2021 10; 31(4):349-360.